KR102507891B1 - 오피오이드와 조합하여 사용하는 팔미토일에탄올아미드 - Google Patents

오피오이드와 조합하여 사용하는 팔미토일에탄올아미드 Download PDF

Info

Publication number
KR102507891B1
KR102507891B1 KR1020150066492A KR20150066492A KR102507891B1 KR 102507891 B1 KR102507891 B1 KR 102507891B1 KR 1020150066492 A KR1020150066492 A KR 1020150066492A KR 20150066492 A KR20150066492 A KR 20150066492A KR 102507891 B1 KR102507891 B1 KR 102507891B1
Authority
KR
South Korea
Prior art keywords
pea
delete delete
palmitoylethanolamide
opioid
micronized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020150066492A
Other languages
English (en)
Korean (ko)
Other versions
KR20150130931A (ko
Inventor
프란체스코 델라 발레
마리아 레데리카 델라 발레
로렌조 디 체사레 마넬리
칼라 게라르디니
Original Assignee
에피테크 그룹 에스. 피. 에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에피테크 그룹 에스. 피. 에이. filed Critical 에피테크 그룹 에스. 피. 에이.
Publication of KR20150130931A publication Critical patent/KR20150130931A/ko
Application granted granted Critical
Publication of KR102507891B1 publication Critical patent/KR102507891B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
KR1020150066492A 2014-05-14 2015-05-13 오피오이드와 조합하여 사용하는 팔미토일에탄올아미드 Active KR102507891B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2014A000876 2014-05-14
ITMI20140876 2014-05-14

Publications (2)

Publication Number Publication Date
KR20150130931A KR20150130931A (ko) 2015-11-24
KR102507891B1 true KR102507891B1 (ko) 2023-03-08

Family

ID=51179022

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150066492A Active KR102507891B1 (ko) 2014-05-14 2015-05-13 오피오이드와 조합하여 사용하는 팔미토일에탄올아미드

Country Status (17)

Country Link
US (1) US9801836B2 (https=)
EP (1) EP2944309B1 (https=)
JP (1) JP6563685B2 (https=)
KR (1) KR102507891B1 (https=)
CN (1) CN105079811B (https=)
AR (1) AR100444A1 (https=)
AU (1) AU2015202575B9 (https=)
BR (1) BR102015011079A2 (https=)
CA (1) CA2891049C (https=)
CY (1) CY1121773T1 (https=)
DK (1) DK2944309T3 (https=)
ES (1) ES2731729T3 (https=)
HU (1) HUE044915T2 (https=)
PL (1) PL2944309T3 (https=)
PT (1) PT2944309T (https=)
SM (1) SMT201900345T1 (https=)
TR (1) TR201908936T4 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42130A (fr) * 2015-05-21 2018-03-28 Therapix Biosciences Ltd Combinaisons d'opioïdes et de n-acyléthanolamines
PH12018000077B1 (en) 2017-07-05 2021-07-09 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
SG10201807034XA (en) 2017-09-05 2019-04-29 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
WO2020141546A1 (en) 2019-01-02 2020-07-09 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for pain management
EP4681710A1 (en) * 2024-07-18 2026-01-21 EPITECH GROUP S.p.A. 2-pentadecyl-2-oxazoline as an opioid adjuvant to prevent or treat hyperalgesia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145858A (ja) 2001-07-18 2007-06-14 Unilever Nv 頭髪及び／または頭皮のトリートメント組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
WO2001010434A1 (en) 1999-08-06 2001-02-15 Innovet Italia S.R.L. Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field
US20050245557A1 (en) * 2003-10-15 2005-11-03 Pain Therapeutics, Inc. Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
MX2011010157A (es) * 2009-03-27 2011-10-11 Abbott Lab Compuestos utiles como ligandos del receptor canabinoide.
KR101662871B1 (ko) * 2009-09-07 2016-10-05 에피테크 그룹 에스.알.엘. 초미세화 팔미토일-에탄올아미드를 함유한 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007145858A (ja) 2001-07-18 2007-06-14 Unilever Nv 頭髪及び／または頭皮のトリートメント組成物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
European Journal of Pharmacology vol.546, no.1-3, pp.60-68 (2006.09.28.)
Inflammopharmacology vol. 22, no.2, pp.79-94 (2013.11.01.)
Pain Management vol.2, no.2, pp.119-124 (2012.03.)
Pain Medicine vol.13, no.9, pp.1121-1130 (2012.09.01.)

Also Published As

Publication number Publication date
CN105079811A (zh) 2015-11-25
TR201908936T4 (tr) 2019-07-22
AU2015202575B2 (en) 2020-03-05
CA2891049A1 (en) 2015-11-14
EP2944309B1 (en) 2019-03-20
ES2731729T3 (es) 2019-11-18
US20150328173A1 (en) 2015-11-19
BR102015011079A2 (pt) 2016-03-29
EP2944309A1 (en) 2015-11-18
SMT201900345T1 (it) 2019-07-11
US9801836B2 (en) 2017-10-31
PT2944309T (pt) 2019-06-05
KR20150130931A (ko) 2015-11-24
CA2891049C (en) 2023-02-21
AU2015202575B9 (en) 2020-03-26
PL2944309T3 (pl) 2019-09-30
AU2015202575A1 (en) 2015-12-03
CY1121773T1 (el) 2020-07-31
CN105079811B (zh) 2020-06-23
JP2015221794A (ja) 2015-12-10
AR100444A1 (es) 2016-10-05
JP6563685B2 (ja) 2019-08-21
DK2944309T3 (da) 2019-06-03
HUE044915T2 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
CN105491885B (zh) 疼痛药物组合及其用途
JP6216305B2 (ja) 薬物過量摂取の治療のためのモルヒナン誘導体
JP6226916B2 (ja) 医薬組成物
KR102507891B1 (ko) 오피오이드와 조합하여 사용하는 팔미토일에탄올아미드
AU2020267217B2 (en) Therapeutic methods employing noribogaine and related compounds
CA2661759A1 (en) Buprenophine-wafer for drug substitution therapy
WO2007005716A2 (en) Methods of treatment and compositions for use thereof
GB2447015A (en) Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
AU2023251499A1 (en) Combinations of opioids and N-acylethanolamines
MX2012005538A (es) Combinacion de farmacos con teobromina y su uso en terapia.
KR20090125748A (ko) 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법
HK1139870A (en) Improved medicinal compositions comprising buprenorphine and naloxone
HK1176006A (en) Improved medicinal composition comprising buprenorphine and naltrexone

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

X091 Application refused [patent]
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601